BioMarin Pharma (BMRN) – Analyst Ratings
-
Wells Fargo Starts BioMarin Pharmaceutical Inc. (BMRN) at Overweight
-
Goldman explores intrinsic and takeover value of BioMarin amid Elliott stake
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BMRN Stock Lookup